Cycloalkane analogues of sinefungin as EHMT1/2 inhibitors

被引:11
|
作者
Liu, Qing [1 ,2 ,3 ]
Cai, Xiaoqing [2 ,3 ]
Yang, Dehua [2 ,3 ]
Chen, Yi [4 ]
Wang, Yafang [4 ]
Shao, Liming [1 ]
Wang, Ming-Wei [1 ,2 ,3 ,4 ]
机构
[1] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
[3] Natl Ctr Drug Screening, Shanghai 201203, Peoples R China
[4] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Methyltransferase inhibitor; Cycloalkyl substituted analogue; Natural product; Sinefungin; METHYLTRANSFERASE G9A; GLP; METHYLATION; MECHANISM;
D O I
10.1016/j.bmc.2017.06.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of cycloalkyl substituted analogues of the natural product sinefungin lacking the amino-acid moiety was designed and synthesized. Two stereoisomers (6-R and 6-S) were separated and their bioactivities examined against EHMT1/2. Of which, compound 14d showed an inhibitory activity against EHMT1/2 (88.9%, IC50 = 21.8 mu M for EHMT1 and 77.6%, IC50 = 39.6 mu M for EHMT2, respectively) similar to that of sinefungin (100.0%, IC50 = 28.4 mu M for EHMT1 and 79.5%, IC50 = 30.1 mu M for EHMT2, respectively). Further studies against other methyltransferases such as PRMT1 showed no activity except that 12d displayed about 20% inhibition. (C) 2017 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4579 / 4594
页数:16
相关论文
共 50 条
  • [1] Analogues of the Natural Product Sinefungin as Inhibitors of EHMT1 and EHMT2
    Devkota, Kanchan
    Lohse, Brian
    Liu, Qing
    Wang, Ming-Wei
    Staerk, Dan
    Berthelsen, Jens
    Clausen, Rasmus Praetorius
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (04): : 293 - 297
  • [2] Analogues of the natural product Sinefungin as potent inhibitors of EHMT1 and EHMT2
    Kanchan Devkota
    Brian Lohse
    Qing Liu
    Ming-Wei Wang
    Jens Berthelsen
    Rasmus Prætorius Clausen
    Epigenetics & Chromatin, 6 (Suppl 1)
  • [3] Novel SAR for quinazoline inhibitors of EHMT1 and EHMT2
    Leenders, Ruben
    Zijlmans, Remco
    van Bree, Bart
    van de Sande, Marc
    Trivarelli, Federica
    Damen, Eddy
    Wegert, Anita
    Mueller, Daniel
    Ehlert, Jan Erik
    Feger, Daniel
    Heidemann-Dinger, Carolin
    Kubbutat, Michael
    Schaechtele, Christoph
    Lenstra, Danny C.
    Mecinovic, Jasmin
    Mueller, Gerhard
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (17) : 2516 - 2524
  • [4] EHMT1 and EHMT2 inhibition induces fetal hemoglobin expression
    Renneville, Aline
    Van Galen, Peter
    Canver, Matthew C.
    McConkey, Marie
    Krill-Burger, John M.
    Dorfman, David M.
    Holson, Edward B.
    Bernstein, Bradley E.
    Orkin, Stuart H.
    Bauer, Daniel E.
    Ebert, Benjamin L.
    BLOOD, 2015, 126 (16) : 1930 - 1939
  • [5] Distinct functions of EHMT1 and EHMT2 in cancer chemotherapy and immunotherapy
    Kang, Zhihua
    Fu, Pan
    Ma, Hui
    Li, Tao
    Lu, Kevin
    Liu, Juan
    Ginjala, Vasudeva
    Romanienko, Peter
    Feng, Zhaohui
    Guan, Ming
    Ganesan, Shridar
    Xia, Bing
    CANCER RESEARCH, 2024, 84 (06)
  • [6] Potential Therapeutics Targeting Upstream Regulators and Interactors of EHMT1/2
    Ang, Gareth Chin Khye
    Gupta, Amogh
    Surana, Uttam
    Yap, Shirlyn Xue Ling
    Taneja, Reshma
    CANCERS, 2022, 14 (12)
  • [7] Systematic evaluation of EHMT1 protein altering variants uncovers unexpected insights on EHMT1 functions and Kleefstra syndrome pathogenesis
    Rots, Dmitrijs
    Yamada, Ayumi
    Foroutan, Aidin
    McCon-Key, Haley
    Kerkhof, Jennifer
    Alders, Marielle
    Maystadt, Isabelle
    Holden, Simon
    Balasubramanian, Meena
    Merla, Giuseppe
    San-Ten, Gijs
    Belonis, Alyce
    Bouman, Arianne
    Kummeling, Joost
    Heijligers, Malou
    Van Haelst, Mieke
    Parker, Michael
    Park, Soo-Mi
    Metcalfe, Kay
    Genevieve, David
    Chatron, Nicolas
    Putoux, Audrey
    Pasquier, Laurent
    Dubourg, Christele
    Strobl-Wildemann, Gertrud
    Plomp, Astrid
    Vreeburg, Maaike
    Baralle, Diana
    Foulds, Nicola
    Scurr, Ingrid
    Cappuccio, Gerarda
    Brunetti-Pierri, Nicola
    Van Hagen, Annet
    Bijlsma, Emilia K.
    Firth, Helen
    Forzano, Francesca
    Kalsner, Louisa
    Hol, Janna A.
    Courage, Carolina
    Vanhoutte, Els
    Banka, Siddharth
    Venselaar, Hanka
    Kasri, N. Nadif
    van Bokhoven, Hans
    Brunner, Han
    Vissers, Lisenka
    Shinkai, Yoichi
    Sadikovic, Bekim
    Kleefstra, Tjitske
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 456 - 457
  • [8] EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms
    Nachiyappan, Alamelu
    Gupta, Neelima
    Taneja, Reshma
    FEBS JOURNAL, 2022, 289 (05) : 1329 - 1351
  • [9] A novel EHMT1 variant in a Turkish case with Kleefstra Syndrome
    Ersoy, Aysenur
    Geckinli, Bilgen Bilge
    Baser, Zeynep
    Hanoglu, Onur
    Kapazan, Cekdar
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1105 - 1105
  • [10] Biochemical validation of EHMT1 missense mutations in Kleefstra syndrome
    Ayumi Yamada
    Chikako Shimura
    Yoichi Shinkai
    Journal of Human Genetics, 2018, 63 : 555 - 562